51 related articles for article (PubMed ID: 1692729)
21. Inhibition of AIDS virus replication by acemannan in vitro.
Kahlon JB; Kemp MC; Carpenter RH; McAnalley BH; McDaniel HR; Shannon WM
Mol Biother; 1991 Sep; 3(3):127-35. PubMed ID: 1768365
[TBL] [Abstract][Full Text] [Related]
22. De novo reverse transcription is a crucial event in cell-to-cell transmission of human immunodeficiency virus.
Li P; Kuiper LJ; Stephenson AJ; Burrell CJ
J Gen Virol; 1992 Apr; 73 ( Pt 4)():955-9. PubMed ID: 1378883
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
[TBL] [Abstract][Full Text] [Related]
24. 5-azacytidine and 5-azadeoxycytidine inhibit human immunodeficiency virus type 1 replication in vitro.
Bouchard J; Walker MC; Leclerc JM; Lapointe N; Beaulieu R; Thibodeau L
Antimicrob Agents Chemother; 1990 Feb; 34(2):206-9. PubMed ID: 1691617
[TBL] [Abstract][Full Text] [Related]
25. Protective activity of tetracycline analogs against the cytopathic effect of the human immunodeficiency viruses in CEM cells.
Lemaître M; Guétard D; Hénin Y; Montagnier L; Zerial A
Res Virol; 1990; 141(1):5-16. PubMed ID: 2326552
[TBL] [Abstract][Full Text] [Related]
26. Exposure of HIV-infected cells to phospholipid leads to membrane alterations and selective growth retardation.
Kerler F; Hübner C; Erfle V; Buff K
Biochim Biophys Acta; 1992 Jun; 1139(1-2):57-64. PubMed ID: 1610919
[TBL] [Abstract][Full Text] [Related]
27. Primary cultures of endothelial cells from the human liver sinusoid are permissive for human immunodeficiency virus type 1.
Steffan AM; Lafon ME; Gendrault JL; Schweitzer C; Royer C; Jaeck D; Arnaud JP; Schmitt MP; Aubertin AM; Kirn A
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1582-6. PubMed ID: 1371878
[TBL] [Abstract][Full Text] [Related]
28. Interaction of HIV-1 with susceptible lymphoblastoid cells. 1H NMR studies.
Luciani AM; Rosi A; Maggiorella MT; Federico M; Sulli N; Verani P; Rossi GB; Viti V; Guidoni L
FEBS Lett; 1991 Jul; 285(1):11-6. PubMed ID: 1712316
[TBL] [Abstract][Full Text] [Related]
29. Lipids and retroviruses.
Raulin J
Lipids; 2000 Feb; 35(2):123-30. PubMed ID: 10757541
[TBL] [Abstract][Full Text] [Related]
30. Cupric and ferric ions inactivate HIV.
Sagripanti JL; Lightfoote MM
AIDS Res Hum Retroviruses; 1996 Mar; 12(4):333-7. PubMed ID: 8906994
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and kinetics of glycerol inactivation of HIV-1 in split skin grafts.
Cameron PU; Pagnon JC; van Baare J; Reece JC; Vardaxis NJ; Crowe SM
J Med Virol; 2000 Feb; 60(2):182-8. PubMed ID: 10596019
[TBL] [Abstract][Full Text] [Related]
32. NMR spectral analysis of cytotoxic ether lipids.
Dick D; Pluskey S; Sukumaran DK; Lawrence DS
J Lipid Res; 1992 Apr; 33(4):605-9. PubMed ID: 1527483
[TBL] [Abstract][Full Text] [Related]
33. Effects of etherlipid analogs on cell membrane functions.
Berkovic D; Wernicke JH; Fleer EA
J Exp Ther Oncol; 2003; 3(4):185-93. PubMed ID: 14567289
[TBL] [Abstract][Full Text] [Related]
34. Regulation of macrophage activation and human immunodeficiency virus production by invasive Salmonella strains.
Mizel SB; Kucera LS; Richardson SH; Ciacci F; Iyer NP
Infect Immun; 1995 May; 63(5):1820-6. PubMed ID: 7729890
[TBL] [Abstract][Full Text] [Related]
35. Growth arrest vs direct cytotoxicity and the importance of molecular structure for the in vitro anti-tumour activity of ether lipids.
Lohmeyer M; Workman P
Br J Cancer; 1995 Aug; 72(2):277-86. PubMed ID: 7640206
[TBL] [Abstract][Full Text] [Related]
36. Membrane-interactive lipids as experimental anticancer drugs.
Berdel WE
Br J Cancer; 1991 Aug; 64(2):208-11. PubMed ID: 1892746
[No Abstract] [Full Text] [Related]
37. Novel membrane-interactive ether lipid analogs that inhibit infectious HIV-1 production and induce defective virus formation.
Kucera LS; Iyer N; Leake E; Raben A; Modest EJ; Daniel LW; Piantadosi C
AIDS Res Hum Retroviruses; 1990 Apr; 6(4):491-501. PubMed ID: 1692729
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
[TBL] [Abstract][Full Text] [Related]
39. Human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 2 (HSV-2) can coinfect and simultaneously replicate in the same human CD4+ cell: effect of coinfection on infectious HSV-2 and HIV-1 replication.
Kucera LS; Leake E; Iyer N; Raben D; Myrvik QN
AIDS Res Hum Retroviruses; 1990 May; 6(5):641-7. PubMed ID: 1972888
[TBL] [Abstract][Full Text] [Related]
40. In vitro evaluation of phosphocholine and quaternary ammonium containing lipids as novel anti-HIV agents.
Meyer KL; Marasco CJ; Morris-Natschke SL; Ishaq KS; Piantadosi C
J Med Chem; 1991 Apr; 34(4):1377-83. PubMed ID: 2016713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
